Annual Retained Earnings
-$2.45 B
-$740.87 M-43.27%
31 December 2022
Summary:
Mirati Therapeutics annual retained earnings is currently -$2.45 billion, with the most recent change of -$740.87 million (-43.27%) on 31 December 2022. During the last 3 years, it has fallen by -$740.87 million (-43.27%).MRTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$2.98 B
-$161.90 M-5.75%
30 September 2023
Summary:
Mirati Therapeutics quarterly retained earnings is currently -$2.98 billion, with the most recent change of -$161.90 million (-5.75%) on 30 September 2023.MRTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRTX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -43.3% | -73.8% |
| 5 y5 years | -217.6% | -285.4% |
MRTX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | >+9999.0% | +9086.0% |
Mirati Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | -$2.98 B(+5.8%) |
| June 2023 | - | -$2.81 B(+6.7%) |
| Mar 2023 | - | -$2.64 B(+7.5%) |
| Dec 2022 | -$2.45 B(+43.3%) | -$2.45 B(+9.0%) |
| Sept 2022 | - | -$2.25 B(+8.4%) |
| June 2022 | - | -$2.08 B(+9.3%) |
| Mar 2022 | - | -$1.90 B(+11.0%) |
| Dec 2021 | -$1.71 B(+51.5%) | -$1.71 B(+13.2%) |
| Sept 2021 | - | -$1.51 B(+5.6%) |
| June 2021 | - | -$1.43 B(+13.1%) |
| Mar 2021 | - | -$1.27 B(+12.0%) |
| Dec 2020 | -$1.13 B(+46.3%) | -$1.13 B(+9.8%) |
| Sept 2020 | - | -$1.03 B(+9.3%) |
| June 2020 | - | -$941.82 M(+9.6%) |
| Mar 2020 | - | -$858.96 M(+11.2%) |
| Dec 2019 | -$772.30 M(+38.1%) | -$772.30 M(+10.3%) |
| Sept 2019 | - | -$699.92 M(+8.4%) |
| June 2019 | - | -$645.65 M(+7.6%) |
| Mar 2019 | - | -$599.96 M(+7.3%) |
| Dec 2018 | -$559.04 M(+21.4%) | -$559.04 M(+5.3%) |
| Sept 2018 | - | -$530.77 M(+5.5%) |
| June 2018 | - | -$503.20 M(+5.9%) |
| Mar 2018 | - | -$475.34 M(+3.2%) |
| Dec 2017 | -$460.63 M(+18.2%) | -$460.63 M(+4.0%) |
| Sept 2017 | - | -$442.73 M(+3.8%) |
| June 2017 | - | -$426.38 M(+4.5%) |
| Mar 2017 | - | -$408.04 M(+4.7%) |
| Dec 2016 | -$389.75 M(+27.1%) | -$389.75 M(+5.3%) |
| Sept 2016 | - | -$370.03 M(+5.5%) |
| June 2016 | - | -$350.61 M(+6.7%) |
| Mar 2016 | - | -$328.55 M(+7.1%) |
| Dec 2015 | -$306.63 M(+26.7%) | -$306.63 M(+6.4%) |
| Sept 2015 | - | -$288.22 M(+7.0%) |
| June 2015 | - | -$269.48 M(+6.1%) |
| Mar 2015 | - | -$254.03 M(+4.9%) |
| Dec 2014 | -$242.09 M | -$242.09 M(+4.5%) |
| Sept 2014 | - | -$231.70 M(+3.9%) |
| June 2014 | - | -$223.09 M(+5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | -$212.05 M(+6.9%) |
| Dec 2013 | -$198.39 M(+41.2%) | -$198.39 M(+6.0%) |
| Sept 2013 | - | -$187.16 M(+18.6%) |
| June 2013 | - | -$157.76 M(+5.8%) |
| Mar 2013 | - | -$149.08 M(+6.1%) |
| Dec 2012 | -$140.49 M(+2.4%) | -$140.49 M(-10.3%) |
| Sept 2012 | - | -$156.61 M(+7.5%) |
| June 2012 | - | -$145.74 M(+1.3%) |
| Mar 2012 | - | -$143.83 M(+4.8%) |
| Dec 2011 | -$137.26 M(+5.3%) | -$137.26 M(+4.3%) |
| Sept 2011 | - | -$131.58 M(-4.5%) |
| June 2011 | - | -$137.80 M(+1.5%) |
| Mar 2011 | - | -$135.80 M(+4.1%) |
| Dec 2010 | -$130.40 M(+18.0%) | -$130.40 M(+4.7%) |
| Sept 2010 | - | -$124.48 M(+6.1%) |
| June 2010 | - | -$117.30 M(-0.5%) |
| Mar 2010 | - | -$117.95 M(+6.7%) |
| Dec 2009 | -$110.51 M(+46.0%) | -$110.51 M(+6.8%) |
| Sept 2009 | - | -$103.44 M(+14.2%) |
| June 2009 | - | -$90.57 M(+16.4%) |
| Mar 2009 | - | -$77.80 M(+2.8%) |
| Dec 2008 | -$75.70 M(-7.7%) | -$75.70 M(-17.5%) |
| Sept 2008 | - | -$91.76 M(-0.4%) |
| June 2008 | - | -$92.16 M(+9.8%) |
| Mar 2008 | - | -$83.97 M(+2.4%) |
| Dec 2007 | -$81.99 M(+61.5%) | -$81.99 M(+9.7%) |
| Sept 2007 | - | -$74.73 M(+15.9%) |
| June 2007 | - | -$64.48 M(+19.1%) |
| Mar 2007 | - | -$54.12 M(+6.6%) |
| Dec 2006 | -$50.77 M(+14.1%) | -$50.77 M(-0.2%) |
| Sept 2006 | - | -$50.89 M(-5.3%) |
| June 2006 | - | -$53.71 M(+12.1%) |
| Mar 2006 | - | -$47.91 M(+7.7%) |
| Dec 2005 | -$44.48 M(+47.0%) | -$44.48 M(+10.6%) |
| Sept 2005 | - | -$40.23 M(+14.9%) |
| June 2005 | - | -$35.00 M(+8.0%) |
| Mar 2005 | - | -$32.40 M |
| Dec 2004 | -$30.26 M(+54.6%) | - |
| Dec 2003 | -$19.57 M | - |
FAQ
- What is Mirati Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Mirati Therapeutics?
What is Mirati Therapeutics annual retained earnings?
The current annual retained earnings of MRTX is -$2.45 B
What is the all time high annual retained earnings for Mirati Therapeutics?
Mirati Therapeutics all-time high annual retained earnings is -$19.57 M
What is Mirati Therapeutics quarterly retained earnings?
The current quarterly retained earnings of MRTX is -$2.98 B
What is the all time high quarterly retained earnings for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly retained earnings is -$32.40 M